glp 1 and bulimia #504: Adult Eating Disorders in the GLP-1 Era GLP-1 Medications and Eating Disorders:
Description
Delivered straight to your door.
The wild card-to-uncertainty about GLP-1 meds growth will be reimbursement: spending will continue to accelerate with upside if more widely reimbursed, IQVIA projects
Michigan's largest health insurer, Blue Cross Blue Shield of Michigan, is stopping coverage for glucagon-like peptide-1 (GLP-1) drugs used for weight loss starting in January 2025
Discover how tirzepatide and metformin together optimize type 2 diabetes control through complementary mechanisms
The NOP already stocks what GLP-1 shoppers wantnow the industry needs to say so before conventional does.
Recently reported by BioSpace, new research highlights the expanding benefits of GLP-1 medications beyond weight loss and diabetes management
